{"title":"Comparison of Image Quality and Safety Profile between Ethiodol and Ioversol Contrast Medium for Hysterosalpingography: A Meta-Analysis.","authors":"Yun Tian, Zhenglong Chen, Peng Chen, Faling Song","doi":"10.1620/tjem.2024.J106","DOIUrl":null,"url":null,"abstract":"<p><p>The selection of an hysterosalpingography (HSG) contrast medium is quite essential due to the different imaging performances and safety profiles among contrast medium during the HSG procedure. Ethiodol and ioversol are the most common contrast mediums, whose superiority of imaging performance and safety profile during HSG is controversial. This meta-analysis aimed to comprehensively compare image quality and safety between infertility patients who received HSG with ethiodol and ioversol. PubMed, Web of Science (WOS), Google Scholar, China National Knowledge Infrastructure (CNKI), Wanfang, and Chongqing VIP (CQVIP) were utilized for literature searching until September 1, 2023. Twelve cohort studies containing 3,622 patients who underwent HSG with ioversol (N = 1,693) or ethiodol (N = 1,929) were included. Ethiodol realized an elevated rate of good and excellent image quality compared to ioversol (risk ratio (RR) = 0.94, 95% confidence intervals (CI): 0.89-1.00, P = 0.035). Whereas the incidence of overall adverse events (AEs) was reduced in patients receiving HSG with ioversol than ethiodol (RR = 0.53, 95% CI: 0.32-0.86, P = 0.011). Nevertheless, incidences of each adverse event, including reflux of contrast medium, abdominal pain, nausea and vomiting, and cough, were not different between patients receiving HSG with ioversol and ethiodol (all P > 0.050). The risk of bias was low, and there was no evidence of publication bias. Meanwhile, sensitivity analysis revealed that the result of image quality was affected by omitting some studies, but most other results were robust. Conclusively, ethiodol realizes improved image quality but ioversol realizes fewer overall AEs for HSG in infertility patients, suggesting that their clinical selection can refer to actual demands.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"1-10"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tohoku Journal of Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1620/tjem.2024.J106","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
The selection of an hysterosalpingography (HSG) contrast medium is quite essential due to the different imaging performances and safety profiles among contrast medium during the HSG procedure. Ethiodol and ioversol are the most common contrast mediums, whose superiority of imaging performance and safety profile during HSG is controversial. This meta-analysis aimed to comprehensively compare image quality and safety between infertility patients who received HSG with ethiodol and ioversol. PubMed, Web of Science (WOS), Google Scholar, China National Knowledge Infrastructure (CNKI), Wanfang, and Chongqing VIP (CQVIP) were utilized for literature searching until September 1, 2023. Twelve cohort studies containing 3,622 patients who underwent HSG with ioversol (N = 1,693) or ethiodol (N = 1,929) were included. Ethiodol realized an elevated rate of good and excellent image quality compared to ioversol (risk ratio (RR) = 0.94, 95% confidence intervals (CI): 0.89-1.00, P = 0.035). Whereas the incidence of overall adverse events (AEs) was reduced in patients receiving HSG with ioversol than ethiodol (RR = 0.53, 95% CI: 0.32-0.86, P = 0.011). Nevertheless, incidences of each adverse event, including reflux of contrast medium, abdominal pain, nausea and vomiting, and cough, were not different between patients receiving HSG with ioversol and ethiodol (all P > 0.050). The risk of bias was low, and there was no evidence of publication bias. Meanwhile, sensitivity analysis revealed that the result of image quality was affected by omitting some studies, but most other results were robust. Conclusively, ethiodol realizes improved image quality but ioversol realizes fewer overall AEs for HSG in infertility patients, suggesting that their clinical selection can refer to actual demands.
期刊介绍:
Our mission is to publish peer-reviewed papers in all branches of medical sciences including basic medicine, social medicine, clinical medicine, nursing sciences and disaster-prevention science, and to present new information of exceptional novelty, importance and interest to a broad readership of the TJEM.
The TJEM is open to original articles in all branches of medical sciences from authors throughout the world. The TJEM also covers the fields of disaster-prevention science, including earthquake archeology. Case reports, which advance significantly our knowledge on medical sciences or practice, are also accepted. Review articles, Letters to the Editor, Commentary, and News and Views will also be considered. In particular, the TJEM welcomes full papers requiring prompt publication.